Skip to main content

Table 1 Data used for testing model/matrices

From: Development and evaluation of a Markov model to predict changes in schistosomiasis prevalence in response to praziquantel treatment: a case study of Schistosoma mansoni in Uganda and Mali

Observed baseline prevalence (%)
Dataset Data type Description Sample size (n) Overall prevalence Low intensity Moderate intensity High intensity
1 Uganda longitudinal baseline to year 3 Full longitudinal data set 747 43.0 16.6 11.4 15.0
2 Uganda longitudinal baseline to year 3 4a Ugandan districts out of 7 400 46.5 15.5 12.3 18.8
3 Uganda cross-sectional baseline to year 3 Varying sample size per year, full programme data Baseline: 4,222;
Year 1: 3,973;
Year 2: 4,192;
Year 3: 3,373
45.2 16.0 11.7 17.6
4 Mali longitudinal baseline to year 2 Full longitudinal data set 897 26.5 12.5 7.1 6.9
  1. aThese districts were selected for their wide range of infection intensities and NOT used to the development of matrix C